New heart failure drug SHR-4658 enters first human safety trial
Disease control
Not yet recruiting
This early-stage trial tests a single injection of SHR-4658 in 48 healthy volunteers and people with slightly high blood pressure. The main goal is to check safety and how the body processes the drug. If it passes safety checks, it may lead to larger studies for heart failure tre…
Phase: PHASE1 • Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC